Literature DB >> 24560089

Novel presentational approaches were developed for reporting network meta-analysis.

Sze Huey Tan1, Nicola J Cooper2, Sylwia Bujkiewicz2, Nicky J Welton3, Deborah M Caldwell3, Alexander J Sutton2.   

Abstract

OBJECTIVES: To present graphical tools for reporting network meta-analysis (NMA) results aiming to increase the accessibility, transparency, interpretability, and acceptability of NMA analyses. STUDY DESIGN AND SETTINGS: The key components of NMA results were identified based on recommendations by agencies such as the National Institute for Health and Care Excellence (United Kingdom). Three novel graphs were designed to amalgamate the identified components using familiar graphical tools such as the bar, line, or pie charts and adhering to good graphical design principles.
RESULTS: Three key components for presentation of NMA results were identified, namely relative effects and their uncertainty, probability of an intervention being best, and between-study heterogeneity. Two of the three graphs developed present results (for each pairwise comparison of interventions in the network) obtained from both NMA and standard pairwise meta-analysis for easy comparison. They also include options to display the probability best, ranking statistics, heterogeneity, and prediction intervals. The third graph presents rankings of interventions in terms of their effectiveness to enable clinicians to easily identify "top-ranking" interventions.
CONCLUSIONS: The graphical tools presented can display results tailored to the research question of interest, and targeted at a whole spectrum of users from the technical analyst to the nontechnical clinician.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Graphical displays, presentational tools, summary forest plot, ranking, probability best; Network meta-analysis

Mesh:

Year:  2014        PMID: 24560089     DOI: 10.1016/j.jclinepi.2013.11.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  13 in total

1.  Quantifying and presenting overall evidence in network meta-analysis.

Authors:  Lifeng Lin
Journal:  Stat Med       Date:  2018-07-18       Impact factor: 2.373

2.  Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.

Authors:  Jianping Zhang; Siobhán Hayes; Brian M Sadler; Ilisse Minto; Julie Brandt; Steve Piscitelli; Sherene Min; Ivy H Song
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

3.  The effectiveness of different interventions to promote poison prevention behaviours in households with children: a network meta-analysis.

Authors:  Felix A Achana; Alex J Sutton; Denise Kendrick; Persephone Wynn; Ben Young; David R Jones; Stephanie J Hubbard; Nicola J Cooper
Journal:  PLoS One       Date:  2015-04-20       Impact factor: 3.240

Review 4.  An overview of conducting systematic reviews with network meta-analysis.

Authors:  Deborah M Caldwell
Journal:  Syst Rev       Date:  2014-09-29

Review 5.  What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review.

Authors:  Shannon M Sullivan; Doug Coyle; George Wells
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

Review 6.  Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.

Authors:  Xiaowei Niu; Jingjing Zhang; Ming Bai; Yu Peng; Shaobo Sun; Zheng Zhang
Journal:  BMC Cardiovasc Disord       Date:  2018-01-10       Impact factor: 2.298

7.  Approaches to interpreting and choosing the best treatments in network meta-analyses.

Authors:  L Mbuagbaw; B Rochwerg; R Jaeschke; D Heels-Andsell; W Alhazzani; L Thabane; Gordon H Guyatt
Journal:  Syst Rev       Date:  2017-04-12

8.  Description of network meta-analysis geometry: A metrics design study.

Authors:  Fernanda S Tonin; Helena H Borba; Antonio M Mendes; Astrid Wiens; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

9.  Evaluating the quality of evidence from a network meta-analysis.

Authors:  Georgia Salanti; Cinzia Del Giovane; Anna Chaimani; Deborah M Caldwell; Julian P T Higgins
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

Review 10.  Comparisons of regular and on-demand regimen of PED5-Is in the treatment of ED after nerve-sparing radical prostatectomy for Prostate Cancer.

Authors:  Shi Qiu; Zhuang Tang; Linghui Deng; Liangren Liu; Ping Han; Lu Yang; Qiang Wei
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.